nodes	percent_of_prediction	percent_of_DWPC	metapath
Perhexiline—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.121	0.17	CbGbCtD
Perhexiline—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.121	0.17	CbGbCtD
Perhexiline—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.108	0.152	CbGbCtD
Perhexiline—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.102	0.143	CbGbCtD
Perhexiline—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0687	0.0966	CbGbCtD
Perhexiline—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0656	0.0921	CbGbCtD
Perhexiline—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0585	0.0821	CbGbCtD
Perhexiline—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0343	0.0482	CbGbCtD
Perhexiline—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0324	0.0455	CbGbCtD
Perhexiline—Papilloedema—Prednisolone—chronic obstructive pulmonary disease	0.00518	0.0279	CcSEcCtD
Perhexiline—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00393	0.0423	CbGpPWpGaD
Perhexiline—Papilloedema—Prednisone—chronic obstructive pulmonary disease	0.00376	0.0203	CcSEcCtD
Perhexiline—Liver injury—Montelukast—chronic obstructive pulmonary disease	0.00354	0.0191	CcSEcCtD
Perhexiline—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00348	0.0374	CbGpPWpGaD
Perhexiline—Weight decreased—Roflumilast—chronic obstructive pulmonary disease	0.0034	0.0183	CcSEcCtD
Perhexiline—Hepatocellular injury—Montelukast—chronic obstructive pulmonary disease	0.00298	0.016	CcSEcCtD
Perhexiline—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00284	0.0306	CbGpPWpGaD
Perhexiline—Optic neuritis—Prednisolone—chronic obstructive pulmonary disease	0.00268	0.0144	CcSEcCtD
Perhexiline—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00257	0.0138	CcSEcCtD
Perhexiline—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00254	0.0137	CcSEcCtD
Perhexiline—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00245	0.0132	CcSEcCtD
Perhexiline—CPT2—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.00232	0.025	CbGpPWpGaD
Perhexiline—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.00227	0.0245	CbGpPWpGaD
Perhexiline—Hypoglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00226	0.0122	CcSEcCtD
Perhexiline—Hypoglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00226	0.0122	CcSEcCtD
Perhexiline—CPT1A—AMPK Signaling—ADIPOQ—chronic obstructive pulmonary disease	0.00219	0.0235	CbGpPWpGaD
Perhexiline—Hypoglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.00213	0.0115	CcSEcCtD
Perhexiline—Hypertriglyceridaemia—Prednisone—chronic obstructive pulmonary disease	0.00208	0.0112	CcSEcCtD
Perhexiline—CPT1A—connective tissue—chronic obstructive pulmonary disease	0.00206	0.214	CbGeAlD
Perhexiline—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00196	0.0106	CcSEcCtD
Perhexiline—CPT2—connective tissue—chronic obstructive pulmonary disease	0.00195	0.203	CbGeAlD
Perhexiline—Optic neuritis—Prednisone—chronic obstructive pulmonary disease	0.00194	0.0105	CcSEcCtD
Perhexiline—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00193	0.0104	CcSEcCtD
Perhexiline—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00186	0.01	CcSEcCtD
Perhexiline—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00186	0.01	CcSEcCtD
Perhexiline—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00184	0.00993	CcSEcCtD
Perhexiline—CPT2—bronchus—chronic obstructive pulmonary disease	0.00183	0.19	CbGeAlD
Perhexiline—Blood triglycerides increased—Prednisone—chronic obstructive pulmonary disease	0.00183	0.00984	CcSEcCtD
Perhexiline—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00175	0.00941	CcSEcCtD
Perhexiline—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00171	0.00923	CcSEcCtD
Perhexiline—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.0017	0.00915	CcSEcCtD
Perhexiline—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.0017	0.00914	CcSEcCtD
Perhexiline—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00169	0.0091	CcSEcCtD
Perhexiline—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00164	0.00881	CcSEcCtD
Perhexiline—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.00163	0.0088	CcSEcCtD
Perhexiline—CPT1A—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.00161	0.0173	CbGpPWpGaD
Perhexiline—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.00157	0.017	CbGpPWpGaD
Perhexiline—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.00157	0.00848	CcSEcCtD
Perhexiline—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.00157	0.0169	CbGpPWpGaD
Perhexiline—CPT2—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.00155	0.0167	CbGpPWpGaD
Perhexiline—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00154	0.00829	CcSEcCtD
Perhexiline—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00153	0.00826	CcSEcCtD
Perhexiline—CPT1A—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	0.00152	0.0164	CbGpPWpGaD
Perhexiline—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.00152	0.0164	CbGpPWpGaD
Perhexiline—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00151	0.00815	CcSEcCtD
Perhexiline—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00149	0.00806	CcSEcCtD
Perhexiline—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00148	0.00796	CcSEcCtD
Perhexiline—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00145	0.0078	CcSEcCtD
Perhexiline—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00144	0.0155	CbGpPWpGaD
Perhexiline—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00141	0.00761	CcSEcCtD
Perhexiline—Shock—Aminophylline—chronic obstructive pulmonary disease	0.0014	0.00755	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.00137	0.0148	CbGpPWpGaD
Perhexiline—CYP2B6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00137	0.0148	CbGpPWpGaD
Perhexiline—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00136	0.00732	CcSEcCtD
Perhexiline—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00136	0.00732	CcSEcCtD
Perhexiline—CPT1A—AMPK Signaling—LEP—chronic obstructive pulmonary disease	0.00136	0.0146	CbGpPWpGaD
Perhexiline—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00135	0.00726	CcSEcCtD
Perhexiline—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00135	0.00725	CcSEcCtD
Perhexiline—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00134	0.00721	CcSEcCtD
Perhexiline—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00134	0.00721	CcSEcCtD
Perhexiline—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.00712	CcSEcCtD
Perhexiline—Tension—Arformoterol—chronic obstructive pulmonary disease	0.0013	0.00703	CcSEcCtD
Perhexiline—Tension—Formoterol—chronic obstructive pulmonary disease	0.0013	0.00703	CcSEcCtD
Perhexiline—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00129	0.00695	CcSEcCtD
Perhexiline—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00129	0.00695	CcSEcCtD
Perhexiline—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00129	0.00694	CcSEcCtD
Perhexiline—CPT1A—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	0.00128	0.0137	CbGpPWpGaD
Perhexiline—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00127	0.00684	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00126	0.0136	CbGpPWpGaD
Perhexiline—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00124	0.00671	CcSEcCtD
Perhexiline—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00124	0.00671	CcSEcCtD
Perhexiline—CPT1A—lung—chronic obstructive pulmonary disease	0.00124	0.129	CbGeAlD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.00124	0.0133	CbGpPWpGaD
Perhexiline—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00124	0.00667	CcSEcCtD
Perhexiline—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00663	CcSEcCtD
Perhexiline—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00657	CcSEcCtD
Perhexiline—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.00657	CcSEcCtD
Perhexiline—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00121	0.00655	CcSEcCtD
Perhexiline—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00121	0.0065	CcSEcCtD
Perhexiline—CPT2—lung—chronic obstructive pulmonary disease	0.00118	0.122	CbGeAlD
Perhexiline—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00633	CcSEcCtD
Perhexiline—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00116	0.00628	CcSEcCtD
Perhexiline—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00114	0.0123	CbGpPWpGaD
Perhexiline—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00113	0.0061	CcSEcCtD
Perhexiline—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00113	0.00608	CcSEcCtD
Perhexiline—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00113	0.00607	CcSEcCtD
Perhexiline—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.00606	CcSEcCtD
Perhexiline—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.00111	0.0119	CbGpPWpGaD
Perhexiline—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00594	CcSEcCtD
Perhexiline—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.00592	CcSEcCtD
Perhexiline—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.00108	0.0117	CbGpPWpGaD
Perhexiline—CPT1A—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.00108	0.0116	CbGpPWpGaD
Perhexiline—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00107	0.00575	CcSEcCtD
Perhexiline—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00106	0.00572	CcSEcCtD
Perhexiline—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.00105	0.0113	CbGpPWpGaD
Perhexiline—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00105	0.00568	CcSEcCtD
Perhexiline—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00105	0.0113	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.00101	0.0109	CbGpPWpGaD
Perhexiline—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00543	CcSEcCtD
Perhexiline—CYP2B6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000997	0.0107	CbGpPWpGaD
Perhexiline—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00099	0.00533	CcSEcCtD
Perhexiline—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000981	0.00528	CcSEcCtD
Perhexiline—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000981	0.00528	CcSEcCtD
Perhexiline—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000976	0.00526	CcSEcCtD
Perhexiline—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00096	0.00518	CcSEcCtD
Perhexiline—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000954	0.00514	CcSEcCtD
Perhexiline—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000953	0.0103	CbGpPWpGaD
Perhexiline—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000942	0.00508	CcSEcCtD
Perhexiline—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000935	0.00504	CcSEcCtD
Perhexiline—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000935	0.00504	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000929	0.01	CbGpPWpGaD
Perhexiline—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000926	0.00499	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000926	0.00996	CbGpPWpGaD
Perhexiline—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000919	0.00495	CcSEcCtD
Perhexiline—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000917	0.00987	CbGpPWpGaD
Perhexiline—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000916	0.00493	CcSEcCtD
Perhexiline—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000906	0.00488	CcSEcCtD
Perhexiline—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000902	0.00486	CcSEcCtD
Perhexiline—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000898	0.00484	CcSEcCtD
Perhexiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000897	0.00966	CbGpPWpGaD
Perhexiline—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000897	0.00484	CcSEcCtD
Perhexiline—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000892	0.00481	CcSEcCtD
Perhexiline—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00089	0.0048	CcSEcCtD
Perhexiline—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000888	0.00479	CcSEcCtD
Perhexiline—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000887	0.00478	CcSEcCtD
Perhexiline—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000887	0.00478	CcSEcCtD
Perhexiline—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000883	0.00476	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000877	0.00944	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000874	0.00941	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000868	0.00468	CcSEcCtD
Perhexiline—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000861	0.00464	CcSEcCtD
Perhexiline—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000861	0.00464	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000859	0.00925	CbGpPWpGaD
Perhexiline—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000858	0.00924	CbGpPWpGaD
Perhexiline—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000857	0.00462	CcSEcCtD
Perhexiline—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000857	0.00462	CcSEcCtD
Perhexiline—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000854	0.0046	CcSEcCtD
Perhexiline—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000847	0.00457	CcSEcCtD
Perhexiline—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000846	0.00456	CcSEcCtD
Perhexiline—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000846	0.00456	CcSEcCtD
Perhexiline—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000844	0.00455	CcSEcCtD
Perhexiline—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000842	0.00454	CcSEcCtD
Perhexiline—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000839	0.00452	CcSEcCtD
Perhexiline—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000837	0.00451	CcSEcCtD
Perhexiline—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000828	0.00892	CbGpPWpGaD
Perhexiline—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000813	0.00438	CcSEcCtD
Perhexiline—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000809	0.00436	CcSEcCtD
Perhexiline—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000798	0.0043	CcSEcCtD
Perhexiline—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000778	0.00419	CcSEcCtD
Perhexiline—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000778	0.00419	CcSEcCtD
Perhexiline—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000766	0.00413	CcSEcCtD
Perhexiline—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000762	0.00411	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.00076	0.00819	CbGpPWpGaD
Perhexiline—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000745	0.00802	CbGpPWpGaD
Perhexiline—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000734	0.00396	CcSEcCtD
Perhexiline—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000726	0.00782	CbGpPWpGaD
Perhexiline—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000717	0.00386	CcSEcCtD
Perhexiline—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000717	0.00386	CcSEcCtD
Perhexiline—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000708	0.00763	CbGpPWpGaD
Perhexiline—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000702	0.00378	CcSEcCtD
Perhexiline—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000693	0.00746	CbGpPWpGaD
Perhexiline—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000689	0.00372	CcSEcCtD
Perhexiline—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000689	0.00372	CcSEcCtD
Perhexiline—Rash—Formoterol—chronic obstructive pulmonary disease	0.000684	0.00368	CcSEcCtD
Perhexiline—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000684	0.00368	CcSEcCtD
Perhexiline—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000683	0.00368	CcSEcCtD
Perhexiline—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000683	0.00368	CcSEcCtD
Perhexiline—Headache—Formoterol—chronic obstructive pulmonary disease	0.000679	0.00366	CcSEcCtD
Perhexiline—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000679	0.00366	CcSEcCtD
Perhexiline—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000679	0.00366	CcSEcCtD
Perhexiline—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000678	0.0073	CbGpPWpGaD
Perhexiline—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000677	0.00365	CcSEcCtD
Perhexiline—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000675	0.00364	CcSEcCtD
Perhexiline—Rash—Montelukast—chronic obstructive pulmonary disease	0.00067	0.00361	CcSEcCtD
Perhexiline—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000669	0.00361	CcSEcCtD
Perhexiline—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000666	0.00717	CbGpPWpGaD
Perhexiline—Headache—Montelukast—chronic obstructive pulmonary disease	0.000665	0.00359	CcSEcCtD
Perhexiline—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000656	0.00353	CcSEcCtD
Perhexiline—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000651	0.00351	CcSEcCtD
Perhexiline—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.00065	0.00699	CbGpPWpGaD
Perhexiline—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000645	0.00348	CcSEcCtD
Perhexiline—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000645	0.00348	CcSEcCtD
Perhexiline—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000645	0.00348	CcSEcCtD
Perhexiline—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000644	0.00347	CcSEcCtD
Perhexiline—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000644	0.00347	CcSEcCtD
Perhexiline—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000641	0.00346	CcSEcCtD
Perhexiline—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000632	0.00341	CcSEcCtD
Perhexiline—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000631	0.0034	CcSEcCtD
Perhexiline—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000623	0.00671	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000623	0.00671	CbGpPWpGaD
Perhexiline—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000623	0.00336	CcSEcCtD
Perhexiline—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000608	0.00328	CcSEcCtD
Perhexiline—CPT1A—Metabolism—APIP—chronic obstructive pulmonary disease	0.000606	0.00652	CbGpPWpGaD
Perhexiline—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0006	0.00645	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000583	0.00627	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000579	0.00623	CbGpPWpGaD
Perhexiline—CYP2B6—respiratory system—chronic obstructive pulmonary disease	0.000578	0.06	CbGeAlD
Perhexiline—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000578	0.00311	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000577	0.00621	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000574	0.00618	CbGpPWpGaD
Perhexiline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00057	0.00613	CbGpPWpGaD
Perhexiline—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000568	0.00306	CcSEcCtD
Perhexiline—CPT2—Metabolism—GC—chronic obstructive pulmonary disease	0.000563	0.00607	CbGpPWpGaD
Perhexiline—CYP2B6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000562	0.00605	CbGpPWpGaD
Perhexiline—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000557	0.003	CcSEcCtD
Perhexiline—CPT1A—AMPK Signaling—TP53—chronic obstructive pulmonary disease	0.000554	0.00596	CbGpPWpGaD
Perhexiline—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000549	0.00591	CbGpPWpGaD
Perhexiline—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000541	0.00583	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000538	0.00579	CbGpPWpGaD
Perhexiline—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000531	0.00286	CcSEcCtD
Perhexiline—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000527	0.00284	CcSEcCtD
Perhexiline—CPT2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000524	0.00564	CbGpPWpGaD
Perhexiline—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00052	0.0056	CbGpPWpGaD
Perhexiline—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000515	0.00554	CbGpPWpGaD
Perhexiline—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000493	0.00531	CbGpPWpGaD
Perhexiline—CYP2B6—bronchus—chronic obstructive pulmonary disease	0.000475	0.0494	CbGeAlD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.00047	0.00506	CbGpPWpGaD
Perhexiline—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000469	0.00253	CcSEcCtD
Perhexiline—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000466	0.00251	CcSEcCtD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000462	0.00497	CbGpPWpGaD
Perhexiline—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000459	0.00248	CcSEcCtD
Perhexiline—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000453	0.00488	CbGpPWpGaD
Perhexiline—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000453	0.00244	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000453	0.00488	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000451	0.00485	CbGpPWpGaD
Perhexiline—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000436	0.00469	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000432	0.00465	CbGpPWpGaD
Perhexiline—Shock—Prednisone—chronic obstructive pulmonary disease	0.00042	0.00226	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000417	0.00449	CbGpPWpGaD
Perhexiline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000414	0.00446	CbGpPWpGaD
Perhexiline—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000412	0.00222	CcSEcCtD
Perhexiline—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000408	0.0044	CbGpPWpGaD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000408	0.00439	CbGpPWpGaD
Perhexiline—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000407	0.00219	CcSEcCtD
Perhexiline—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000405	0.00436	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000401	0.00432	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000398	0.00429	CbGpPWpGaD
Perhexiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000396	0.00426	CbGpPWpGaD
Perhexiline—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000391	0.00421	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GC—chronic obstructive pulmonary disease	0.00039	0.0042	CbGpPWpGaD
Perhexiline—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000388	0.00209	CcSEcCtD
Perhexiline—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000386	0.00208	CcSEcCtD
Perhexiline—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000383	0.00206	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000381	0.00411	CbGpPWpGaD
Perhexiline—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000371	0.002	CcSEcCtD
Perhexiline—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00037	0.002	CcSEcCtD
Perhexiline—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00037	0.00199	CcSEcCtD
Perhexiline—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000368	0.00198	CcSEcCtD
Perhexiline—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000368	0.00198	CcSEcCtD
Perhexiline—CPT1A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000363	0.00391	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000349	0.00188	CcSEcCtD
Perhexiline—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000349	0.00188	CcSEcCtD
Perhexiline—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000339	0.00183	CcSEcCtD
Perhexiline—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000337	0.00182	CcSEcCtD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000336	0.00361	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000327	0.00352	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000321	0.00346	CbGpPWpGaD
Perhexiline—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00032	0.00345	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000308	0.00331	CbGpPWpGaD
Perhexiline—CYP2B6—lung—chronic obstructive pulmonary disease	0.000307	0.0319	CbGeAlD
Perhexiline—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000306	0.00165	CcSEcCtD
Perhexiline—CPT2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000304	0.00328	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000295	0.00318	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000292	0.00314	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000289	0.00311	CbGpPWpGaD
Perhexiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000288	0.0031	CbGpPWpGaD
Perhexiline—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000284	0.00306	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000284	0.00305	CbGpPWpGaD
Perhexiline—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000282	0.00152	CcSEcCtD
Perhexiline—CPT2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000278	0.00299	CbGpPWpGaD
Perhexiline—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000271	0.00146	CcSEcCtD
Perhexiline—Rash—Prednisone—chronic obstructive pulmonary disease	0.000269	0.00145	CcSEcCtD
Perhexiline—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000269	0.00145	CcSEcCtD
Perhexiline—Headache—Prednisone—chronic obstructive pulmonary disease	0.000267	0.00144	CcSEcCtD
Perhexiline—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000265	0.00285	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000264	0.00284	CbGpPWpGaD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000259	0.00279	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000256	0.00275	CbGpPWpGaD
Perhexiline—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000255	0.00275	CbGpPWpGaD
Perhexiline—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000253	0.00137	CcSEcCtD
Perhexiline—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000245	0.00264	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000242	0.0026	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	0.000235	0.00253	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000233	0.00251	CbGpPWpGaD
Perhexiline—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000233	0.0025	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	0.000215	0.00232	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000213	0.0023	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000213	0.0023	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000211	0.00227	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.00021	0.00227	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00021	0.00226	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000205	0.00221	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000205	0.0022	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000203	0.00218	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000202	0.00217	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000197	0.00212	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000196	0.00211	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000192	0.00207	CbGpPWpGaD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000188	0.00202	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000188	0.00202	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000186	0.002	CbGpPWpGaD
Perhexiline—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000186	0.002	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000185	0.002	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000178	0.00192	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000177	0.00191	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000176	0.00189	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00017	0.00184	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000168	0.00181	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000152	0.00164	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000148	0.00159	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000146	0.00157	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	0.000143	0.00154	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000142	0.00153	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00014	0.00151	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000136	0.00146	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000134	0.00144	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000133	0.00143	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000131	0.00141	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000129	0.00139	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000129	0.00139	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ALB—chronic obstructive pulmonary disease	0.000126	0.00136	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000124	0.00133	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.00132	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000121	0.0013	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.0012	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.00118	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	9.97e-05	0.00107	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.5e-05	0.00102	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.3e-05	0.001	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	9.24e-05	0.000995	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.17e-05	0.000987	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ALB—chronic obstructive pulmonary disease	8.76e-05	0.000943	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.59e-05	0.000925	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.54e-05	0.00092	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.43e-05	0.000907	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—NOS3—chronic obstructive pulmonary disease	8.38e-05	0.000902	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.1e-05	0.000872	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.99e-05	0.00086	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.6e-05	0.000711	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	6.52e-05	0.000702	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	6.42e-05	0.000691	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.97e-05	0.000643	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.05e-05	0.000543	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	4.99e-05	0.000537	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	4.55e-05	0.00049	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.32e-05	0.000465	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	4.2e-05	0.000452	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.2e-05	0.000452	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.9e-05	0.00042	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.51e-05	0.000378	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.5e-05	0.000377	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	3.47e-05	0.000373	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.45e-05	0.000372	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.22e-05	0.000346	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	3.16e-05	0.000341	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.05e-05	0.000328	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.92e-05	0.000314	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.43e-05	0.000262	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.4e-05	0.000258	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.29e-05	0.000247	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.27e-05	0.000244	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.23e-05	0.000241	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.12e-05	0.000228	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	2.07e-05	0.000223	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.07e-05	0.000223	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.98e-05	0.000213	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.91e-05	0.000205	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.59e-05	0.000171	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.57e-05	0.000169	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.46e-05	0.000157	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	1.44e-05	0.000155	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.39e-05	0.000149	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.38e-05	0.000148	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	9.42e-06	0.000101	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	9.01e-06	9.7e-05	CbGpPWpGaD
